Ryogen LLC is a genetic company with a substantial intellectual property portfolio focused on significant genetic biomarkers.
Ryogen makes its valuable intellectual property accessible to researchers through strategic licensing opportunities.
Our extensive IP portfolio includes 36 issued US patents and multiple patent applications targeting diverse genetic biomarkers with applications across biomedical research, diagnostics, and drug development.